Sat, Apr 19, 2014, 2:19 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Berkshire Hathaway Inc. Message Board

gatsbyrising 2 posts  |  Last Activity: Feb 27, 2014 10:05 PM Member since: Feb 25, 2005
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • gatsbyrising by gatsbyrising Feb 27, 2014 10:05 PM Flag

    Biotechs are on fire right now and Wall Street cant get enough of them and then you have NKTR ...that isues more shares and misses revenues and earnings by a considerable amount. I saw someone post that NKTR would get royalties of 2 to 3 per cent if a certain drug was apporoved is it even worthit for shareholders to wait for years for a drug to get approval and then get 3 per cent income stream from a new drug big mistake buying this stcok it looks like down big time after hours too...

  • gatsbyrising by gatsbyrising Feb 11, 2014 9:09 PM Flag

    This stock reminds me of ISIS Pharmacueticals 15 years ago. Lotsof potential but they need to get something approved.. ISIS went years without a major drug getting aprroved and is just now bringing major drugs to the marker and starting to got share appreication that many thought would happen long ago. Another bio tech i owned was Incyte INCY I bought at 17 and sold at 25 the stock is now at 65 all this in the last year. INCY has about 150 million in sales and the market cap is 10 billion i read an article from Goldman Sachs that said INCY was fully valued at 25 a share so i sold .. big mistake Can you Imagine what how much NKTR would be valued at if their non narcotic drug for pain was approved ??? If a dr had the choice of prescribing a pain killer that wasnt addictive vs a drug like oxycotin.. what do you think they would choose to prescribe.. I dont know enough about the science to kno if NKTR pain candidate would compete with the major pain killers but see the potental of NKTR if the drugs in the pipeline can get approved but approvals can take years and years

127.18+1.18(+0.94%)Apr 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Weibo Corporation
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT